EMCDDA Home
  • EN
Search

Stay informed

Follow us on Twitter

Follow us on 

Subscribe to RSS news feed RSS feed

Media support

To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations unit:

Kathy Robertson
Head of sector
Media relations and marketing
Tel: (351) 211 21 02 00/32
Fax: (351) 211 21 03 80

Maria José Louro
Media relations assistant
Tel: (351) 211 21 02 00/40
Fax: (351) 211 21 03 80

New prize for europe’s top scientific papers on drugs

EMCDDA to acknowledge excellence in scientific writing

Lisbon, 04.03.2011 (Fact sheet No 1/2011)

Download fact sheet

Fact sheet (Word)
Download this attachment in DOC format
Fact sheet (PDF)
Download this attachment in PDF format

Europe’s top scientific papers on drug-related topics will be acknowledged this year in a new award launched by the EU drugs agency (EMCDDA). The prize giving, to take place annually in Lisbon, will celebrate excellence in scientific writing in this area of critical concern to EU citizens. The inaugural event will take place in the margins of the EMCDDA Scientific Committee meeting, being held in the Portuguese capital from 14–15 November. This EMCDDA advisory body is composed of 16 renowned scientists appointed on the basis of merit and independence.

Articles eligible for nomination for the award will focus on illicit drugs, although findings on licit substances may also be included. The articles will have been published in 2010 in peer-reviewed scientific journals, with the primary author based in an EU Member State or Norway.

Entries may be submitted in any of the 23 languages of the European Union or in Norwegian, along with an abstract in English.

The acclaimed articles will meet the criteria of:

  • scientific significance;
  • EU policy relevance;
  • originality and creativity;
  • clarity and quality of writing.

The importance of scientific publishing has been underlined regularly by the Scientific Committee as evidence of scientific excellence. The upcoming (non-monetary) prize originated in these discussions.

Commenting on the initiative, EMCDDA Director Wolfgang Götz said: ‘Our Scientific Committee provides a strong voice for scientific standards and I welcome its initiative for lauding the best scientific papers in our field of drugs and drug addiction. Ensuring that the findings of European research are made available to the policy and practice community is an important issue. I hope this award will become a useful channel for disseminating these results‘.

The award is now open. Nominations close on 2 May 2011.

The jury — composed of members of the Committee and EMCDDA staff — will select up to 10 top articles from a variety of disciplines, nationalities and languages.

Notification of the selected articles will also be made via the EMCDDA website and publications. 

Editors of journals in which a successful article was published will be informed of the outcome of the award.

Notes

Details on how to enter including eligibility requirements are available in this document.

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. Read more >>

Contact us

EMCDDA
Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 04 March 2011